Connecting the Dots on Celiac Disease, Non-Celiac Gluten Sensitivity, and Crohn’s Disease.
In the U.S., 2 in 5 Americans are affected by GI disorders.
This Celiac, IBS, and Crohn’s Array (CICA) evaluates your genetic risk for celiac disease and Crohn’s disease, serum markers associated with an active celiac disease process, and serum markers associated with active Crohn’s disease.
Physician Reviewed Results
Method Health tests are reviewed between you and one of our board-certified physicians—In-person or via telehealth.
We accept HSA/FSA payments
In the United States, an estimated 60-70 million people are affected by gastrointestinal disorders (GI). Celiac disease may be present despite the absence of GI symptoms, particularly, in relatives of individuals with celiac disease.
Who may benefit from this Celiac, IBS, Crohn’s test?